Literature DB >> 15367057

Ziprasidone in the acute treatment of borderline personality disorder in psychiatric emergency services.

Juan C Pascual, Silvia Oller, Joaquim Soler, Judith Barrachina, Enrique Alvarez, Victor Pérez.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15367057     DOI: 10.4088/jcp.v65n0918b

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


× No keyword cloud information.
  10 in total

1.  Self-mutilation and pharmacotherapy.

Authors:  Brian Daniel Smith
Journal:  Psychiatry (Edgmont)       Date:  2005-10

Review 2.  Aggression in borderline personality disorder.

Authors:  K Látalová; J Prasko
Journal:  Psychiatr Q       Date:  2010-09

Review 3.  [Treatment of borderline personality disorder with atypical antipsychotic drugs].

Authors:  A Mobascher; J Mobascher; C Schmahl; J Malevani
Journal:  Nervenarzt       Date:  2007-09       Impact factor: 1.214

Review 4.  Medications in the treatment of borderline personality disorder 2006.

Authors:  Deanna Mercer
Journal:  Curr Psychiatry Rep       Date:  2007-02       Impact factor: 8.081

5.  Paliperidone ER in the Treatment of Borderline Personality Disorder: A Pilot Study of Efficacy and Tolerability.

Authors:  Silvio Bellino; Paola Bozzatello; Camilla Rinaldi; Filippo Bogetto
Journal:  Depress Res Treat       Date:  2011-08-04

Review 6.  Patients with Borderline Personality Disorder in Emergency Departments.

Authors:  Untara Shaikh; Iqra Qamar; Farhana Jafry; Mudasar Hassan; Shanila Shagufta; Yassar Islamail Odhejo; Saeed Ahmed
Journal:  Front Psychiatry       Date:  2017-08-04       Impact factor: 4.157

7.  Auditory Verbal Hallucinations in Borderline Personality Disorder and the Efficacy of Antipsychotics: A Systematic Review.

Authors:  Christina W Slotema; Jan Dirk Blom; Marieke B A Niemantsverdriet; Iris E C Sommer
Journal:  Front Psychiatry       Date:  2018-07-31       Impact factor: 4.157

8.  High-dose antipsychotic drug use as a predictor for readmission of inpatients with borderline personality disorder: A retrospective chart review in a Japanese psychiatric hospital.

Authors:  Yuji Yamada; Yuma Yokoi; Zui Narita; Naotsugu Hirabayashi
Journal:  Neuropsychopharmacol Rep       Date:  2020-10-10

9.  Second-generation antipsychotic use in borderline personality disorder: What are we targeting?

Authors:  Adrian Wasylyshen; Andrew M Williams
Journal:  Ment Health Clin       Date:  2016-03-08

Review 10.  Current Clinical Psychopharmacology in Borderline Personality Disorder.

Authors:  Antonio Del Casale; Luca Bonanni; Paride Bargagna; Francesco Novelli; Federica Fiaschè; Marco Paolini; Francesca Forcina; Gaia Anibaldi; Francesca Natalia Cortese; Alessia Iannuccelli; Barbara Adriani; Roberto Brugnoli; Paolo Girardi; Joel Paris; Maurizio Pompili
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.